Comprehensive Molecular Tumor Analysis (CMTA) integrating RNAseq and TME for targeted therapy
On Demand
55mins
Alacris Theranostics' Comprehensive Molecular Tumor Analysis (CMTA) uses whole exome and transcriptome sequencing with MGI DNBSEQ technology. It's beneficial for guiding targeted therapies in complex or unknown tumors, enhancing personalized cancer treatment plans.
Dr. Marie-Laure Yaspo - Co-founder and Chief Scientific Officer @ Alacris Theranostics GmbH
Priyanka Kurapati - Field Application Scientist @ MGI-tech
Jun 6, 2023
1hr 6mins
Jun 13, 2023
1hr 21mins
Jun 20, 2023
1hr 27mins
Aug 16, 2023
1hr 19mins
Oct 26, 2023
1hr 58mins
Dec 13, 2023
1hr 59mins
Feb 1, 2024
1:04:45
Mar 6, 2024
43min
Apr 24, 2024
46.51
May 20, 2024